CRL
Charles River Laboratories International, Inc.$226.79+0.54% 1D· price as of Jun 30, 8:32 PM+49.61% over 1Y
Compare:CRL
Mkt Cap
$10.9B
P/E
—
Fwd P/E
18.4×
PEG
0.12
P/B
3.7×
P/S
2.7×
EV/EBITDA
15.6×
Beta
1.45
Div Yield
0.0%
Payout
0.0%
ROE
-5.9%
Net Margin
-4.6%
Short % Flt
7.6%
Inst. Own
123.4%
52-wk low $144.26$226.7952-wk high $228.88
+57.2% above low-0.9% from high
Seasonality — avg monthly return
Strongest Jul 11.3% · weakest Apr -7.7%Jan
-1.8
Feb
-1.4
Mar
-2.5
Apr
-7.7
May
+2.3
Jun
+7.6
Jul
+11.3
Aug
-6.6
Sep
-4.2
Oct
+1.6
Nov
+3.3
Dec
+4.6
Average month-over-month return per calendar month over the available history (~5 yrs); hover for the share of positive months. Past seasonality isn't predictive.
Ask AI about Charles River Laboratories International, Inc.
Gemini · web searchSearches the live web for current news & events plus this company's financials — and you can keep asking follow-up questions.
CRL — recent news
Loading headlines…
Quality scorecard
vs Life Sciences Tools & Services · 8 peers · percentile rank
19 / 100
Weak
ROIC5.9%
14
ROE-4.6%
14
Gross margin33.0%
0
Operating margin10.0%
0
FCF yield5.0%
86
Net debt / EBITDA5.7×
0
Percentile vs 8 Life Sciences Tools & Services peers — higher = better (leverage inverted: less debt ranks higher). The faint tick is the peer median; the score is the average percentile. Annual fundamentals.